Newborn Screening in Bisha region, Saudi Arabia: A 14 Years Retrospective Study on the Incidence of Inborn Errors of Metabolism and Comparisons with Regional and Global Data
Abstract
Background: Newborn screening (NBS) is a population-based public health program designed to identify newborns with serious but treatable inborn error of metabolism disorders before the onset of clinical symptoms. Early diagnosis through NBS enables timely intervention, thereby reducing morbidity, mortality, and long-term disability. Saudi Arabia has one of the highest reported incidences of inborn error of metabolism and endocrine disorders worldwide, largely attributed to the high prevalence of consanguineous marriages. Objective: To determine the incidence of inborn error of metabolism and endocrine disorders detected through the Saudi National Newborn Screening Program in the Bisha region over a 14-year period and to compare the findings with national and international incidence data. Methods: A retrospective observational study was conducted using data collected between January 1, 2006, and December 31, 2019. During the study period, 73,571 newborns, representing 97.3% of all live births (73,571/75,600), underwent newborn screening in Ministry of Health hospitals in the Bisha region. Heel-prick dried blood spot samples were collected between 24 and 72 hours after birth and analyzed at the National Health Laboratory using tandem mass spectrometry and immunofluorometric assays. Only laboratory-confirmed cases were included in the analysis. Disease incidences were calculated and compared with previously published data from other Saudi regions and international populations. Results: Among 73,571 screened newborns, 78 were diagnosed with inherited metabolic or endocrine disorders, corresponding to an overall incidence of approximately 1 in 943 live births. Argininosuccinate lyase deficiency (ASLD) was the most frequently detected disorder (19 cases; incidence 1: 3,872), congenital hypothyroidism (19 cases; 1:3,872), and Propionic acidemia/methylmalonic acidemia (PA/MMA) (9 cases; 1:8,174). Compared with published Saudi and international data, Bisha region has high overall incidence, ASLD and PA/MMA were markedly higher in the Bisha region. Conclusion: The Bisha region demonstrates high overall incidence of 1:943 and a substantially higher incidence of ASLD and PA/MMA than what has been reported from other regions and internationally. This may reflect the influence of consanguinity and founder mutations within the local population. These findings emphasize the importance of maintaining comprehensive newborn screening services and support the implementation of enhanced genetic counseling, premarital screening, and targeted carrier screening in high-risk communities.